Aldazide

Aldazide 25: Each film coated tablet contains: Spironolactone 25 mg,

Hydrochlorothiazide 25 mg.

Aldazide 50: Each film coated tablet contains: Spironolactone 50 mg,

Hydrochlorothiazide 50 mg.

Pharmaceutical form: Tablets.
Therapeutic category: Diuretic.

Composition:

Aldazide 25: Each film coated tablet contains: Spironolactone 25 mg,

Hydrochlorothiazide 25 mg.

Aldazide 50: Each film coated tablet contains: Spironolactone 50 mg,

Hydrochlorothiazide 50 mg.

 

Indications:

Aldazide is indicated for:

- Edmatous conditions for patients with:

1- Congestive heart failure.

2- Cirrhosis of the liver accompanied by edema and /or ascites.

3- Nephrotic syndrome.

- Essential hypertension.

 

Dosage:

- Edema in adults ( congestive heart failure, hepatic cirrhosis, or nephritic

syndrome) the usual maintenance dose is 100 mg each of spironolactone and

Hydrochlorothiazide daily administered in a single dose or in divided doses but

range from 25 mg to 200 mg of each component daily.

- Children: the usual daily maintenance dose of Aldazide should be that provide

1.65 mg to 3.3 mg of spironolactone /Kg of body weight.

- Essential hypertension: 50 mg to 100 mg each spironolactone and

Hydrochlorothiazide daily given in a single dose or in divided doses. Concurrent

potassium supplementation is not recommended when the drug is used in long

term therapy.

 
 
Home Page | About Us |  Products |  Facilities | Policies | Contact Us | Site Map